Radiation Oncology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
Otorhinolaryngology, Head and Neck Surgery, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan.
BMJ Case Rep. 2021 Nov 30;14(11):e246084. doi: 10.1136/bcr-2021-246084.
External-beam radiation therapy (EBRT) for differentiated thyroid cancer has been controversial. Palliative irradiation is usually recommended for patients with treatment-resistant relapse and/or distant metastases, but high-dose EBRT is not often indicated in this situation. A 50-year-old man had treatment-resistant recurrence of an inoperable cervical mass and multiple lung metastases after total thyroidectomy and neck dissection. Because the patient had good performance status and no other life-threatening metastases, he received high-dose intensity-modulated radiation therapy (IMRT). Remarkably, the tumour shrank during treatment. After 3 months, he had bleeding from the internal carotid artery. The bleeding was outside the high-dose irradiation site and was likely due to infection; emergency interventional radiology was performed. The post-EBRT clinical course was favourable and the cervical mass almost disappeared. The patient remained alive for 3 years post treatment. It is possible to extend the indication of high-dose intensity-IMRT in selected patients with differentiated thyroid cancer.
对于分化型甲状腺癌的外部束放射治疗(EBRT)一直存在争议。对于治疗抵抗性复发和/或远处转移的患者,通常建议姑息性照射,但在这种情况下通常不建议使用高剂量 EBRT。一名 50 岁男性在全甲状腺切除术和颈部清扫术后出现不可切除的颈部肿块和多发肺转移,发生治疗抵抗性复发。由于患者的一般情况良好,且没有其他危及生命的转移,他接受了高剂量强度调制放射治疗(IMRT)。值得注意的是,肿瘤在治疗过程中缩小了。3 个月后,他出现颈内动脉出血。出血不在高剂量照射部位,可能是由于感染所致;紧急介入放射治疗。EBRT 后的临床过程良好,颈部肿块几乎消失。治疗后患者存活了 3 年。在选择的分化型甲状腺癌患者中,可能扩大高剂量强度-IMRT 的适应证。